J.-L. Montchamp / Journal of Organometallic Chemistry 690 (2005) 2388–2406
[21] Y.R. Dumond, J.-.L. Montchamp, J. Organomet. Chem. 653 (2002) 252.
2405
[22] Z. Huang, K. Bravo-Altamirano, J.-.L. Montchamp, Comptes. Rendus Chimie. 7 (8-9) (2004) 763.
[23] (a) K. Bravo-Altamirano, Z. Huang, J.-L. Montchamp, unpublished results;
(b) Abstracts of the 228th National Meeting of the American Chemical Society, Division of Organic Chemistry, paper # 751465, poster 580,
Philadelphia, PA, August 22–26, 2004.
[24] (a) Reviews C. Walling, M.S. Pearson, Top Phosphorus Chem. 3 (1966) 1;
(b) H. Halmann, Top Phosphorus Chem. 4 (1967) 49;
(c) W.G. Bentrude, in: J.k. kochi (Ed.), Free Radicals, vol. 2, Wiley, New York, 1973 (Chapter 22);
(d) W.G. Bentrude, in: F.R. Hartley (Ed.), The Chemistry of Organophosphorus compounds, vol.1, Wiley, New York, 1990 (Chapter 14);
(e) F.W. Stacey, J.F. Harris, Org. React. 13 (1963) 150.
[25] R.H. Williams, L.A. Hamilton, J. Am. Chem. Soc. 77 (1955) 3411.
[26] N.G. Anderson, M.L. Coradetti, J.A. Cronin, M.L. Davies, M.B. Gardineer, A.S. Kotnis, D.A. Lust, V.A. Palaniswamy, Org. Process Res.
Dev. 1 (1997) 315.
`
[27] S. Deprele, J.-.L. Montchamp, J. Org. Chem. 66 (2001) 6745.
[28] S.J. Fitch, J. Am. Chem. Soc. 86 (1964) 61.
[29] E.E. Nifantꢀev, L.P. Levitan, J. Gen. Chem. USSR 35 (1965) 762.
[30] E.E. Nifantꢀev, M.P. Koroteev, J. Gen. Chem. USSR 37 (1967) 1366.
`
[31] (a) S. Deprele, J.-L. Montchamp, unpublished results;
(b) Depre`le S Phosphorus-Carbon Bond Formation: New Methodologies for Hydrophosphinylation Reactions, Ph.D. Thesis, May 2004, Texas
Christian University.
[32] M.I. Antczak, J.-L., Montchamp, unpublished results.
[33] (a) E.E. Nifantꢀev, L.A. Solovetskaya, V.I. Maslennikova, R.K. Magdeeva, N.M. Sergeev, J. Gen. Chem. USSR 56 (1986) 680;
(b) E.E. Nifantꢀev, R.K. Magdeeva, L.A. Solovetskaya, N.M. Sergeev, J. Gen. Chem. USSR 54 (1984) 630.
`
[34] S. Deprele, J.-L. Montchamp, Bis-H-Phosphinic Acid Derivatives as Precursors to Therapeutic Bisphosphonates and Uses Thereof, US Patent
Number US 6,781,011 B2 (August 24, 2004).
`
[35] S. Deprele, A. Sutor, J.-L., Montchamp, manuscript in preparation.
[36] Bisphosphonate syntheses: (a) G.R. Kieczykowski, R.B. Jobson, D.G. Melillo, D.F. Reinhold, V.J. Grenda, I. Shinkai, J. Org. Chem. 60 (1995)
8310, and references cited;
(b) T.A. Bandurina, V.N. Konyukhov, O.A. Ponomareva, A.S. Barybin, Z.V. Pushkareva, Khim. Farm Zh. (Engl. Trans.) 12 (1978) 1428;
(c) M. Lecouvey, Y. Leroux, Heteroatom Chem. 11 (2000) 556;
(d) J. Vepsa¨la¨inen, E. Pohjala, H. Nupponen, P. Vainiotalo, M. Ahlgren, Phosphorus Sulfur Silicon 70 (1992) 183;
(e) B.K. Shcherbakov, F.I. Belꢀskii, A.Y. Gukasova, Y.M. Polikarpov, M.I. Kabachnik, Russ. Chem. Bull 47 (1998) 1732;
(f) F.H. Ebetino, E.G. Soyke Jr., S.M. Dansereau, Heteroatom Chem. 11 (2000) 442;
(g) G.M. Kosolapoff, J. Am. Chem. Soc. 75 (1953) 1500;
(h) H.R. Hays, T.J. Logan, J. Org. Chem. 31 (1966) 3391;
(i) See also Ref. [38i].
[37] (a) Reviews G.A. Rodan, Annu. Rev. Pharmacol. Toxicol 38 (1998) 375;
(b) G.R. Mundy, Annu. Rev. Med. 53 (2002) 537;
(c) K.M. Prestwood, C.C. Pilbeam, L.G. Raisz, Annu. Rev. Med. 46 (1995) 249;
(d) H. Fleisch, Bisphosphonates in Bone Disease, Academic Press, San Diego, 2000;
(e) O.L.M Bijvoet, H.A. Fleisch, R.E. Canfield, R.G.G. Russell (Eds.), Bisphosphonate on Bones, Elsevier, Amsterdam, 1995;
(f) B. Thurlimann, Bisphosphonates in Clinical Oncology: The Development of Pamidronate, New York, Verlag, 1999;
¨
(g) , Other references on the biological activity and uses of bisphosphonatesH. Fleisch, Drugs 42 (1991) 919;
(h) A.H.G. Paterson, Cancer 88 (2000) 3038;
(i) I.J. Diel, E.-.F. Solomayer, G. Bastert, Cancer 88 (2000) 3080;
(j) A. Lipton, Cancer 88 (2000) 3033;
(k) P.P. Major, A. Lipton, J. Berenson, G. Hortobagyi, Cancer 88 (2000) 6;
(l) J.R. Berenson, A. Lipton, Ann. Rev. Med. Chem. 50 (1999) 237;
(m) E. van Beek, E. Pieterman, L. Cohen, C. Lowik, S. Papapoulos, Biochem. Biophys. Res. Commun. 264 (1999) 108;
(n) J. Flach, I. Antoni, P. Villemin, C.L. Bentzen, E.J. Niesor, Biochem. Biophys. Res. Commun. 270 (2000) 240;
(o) M.B. Martin, W. Arnold, H.T. Heath III, J.A. Urbina, E. Oldfield, Biochem. Biophys. Res. Commun. 263 (1999) 754;
(p) E. van Beek, E. Pieterman, L. Cohen, C. Lowik, S. Papapoulos, Biochem. Biophys. Res. Commun. 255 (1999) 491;
(q) M.J. Rogers, R.J. Brown, V. Hodkin, G.M. Blackburn, R.G.G. Russell, D.J. Watts, Biochem. Biophys. Res. Commun. 224 (1996) 863;
(r) C.M. Szabo, Y. Matsumura, S. Fukura, M.B. Martin, J.M. Sanders, S. Sengupta, J.A. Cieslak, T.C. Loftus, C.R. Lea, H.-.J. Lee, A.
Koohang, R.M. Coates, H. Sagami, E.J. Oldfield, Med. Chem. 45 (2002) 2185;
(s) M.B. Martin, J.S. Grimley, J.C. Lewis, H.T. Heath III, B.N. Bailey, H. Kendrick, V. Yardley, A. Caldera, R. Lira, J.A. Urbina, S.N.J.
Moreno, R. Docampo, S.L. Croft, E.J. Oldfield, Med. Chem. 44 (2001) 909;
(t) D.S. Alberts, A.V. Hallum III, M. Stratton-Custis, J. Dava, D.J. Garcia, M. Gleason-Guzman, S.E. Salmon, P. Santabarbara, E.J. Niesor,
S. Floret, C.L. Bentzen, Clin. Cancer Res. 7 (2001) 1246.
´ ´
[38] Bisphosphonate Conjugates: [methotrexate] (a) G. Sturtz, G. Appere, K. Breistol, O. Fodstad, G. Schwartsmann, H.R. Hendriks, Eur. J. Med.
Chem. 27 (1992) 825;
(b) [doxorubicin]O. Fabulet, G. Sturtz, Phosphorus Sulfur Silicon 101 (1995) 225;
(c) [protein]H. Uludag, T. Gao, G.R. Wohl, D. Kantoci, R.F. Zernicke, Biotechnol. Prog. 16 (2000) 1115;
(d) [protein]H. Uludag, N. Kousinioris, T. Gao, D. Kantoci, Biotechnol. Prog. 16 (2000) 258;
(e) [fluoroquinolones]P. Herczegh, T.B. Buxton, J.C. McPherson III, A. Kovacs-Kulyassa, P.D. Brewer, F. Sztaricskai, G.G. Stroebel, K.M.
Plowman, D. Farcasiu, J.F. Hartmann, J. Med. Chem. 45 (2002) 2338;
(f) [steroids]P.C.B. Page, M.J. McKenzie, J.A. Gallagher, J. Org. Chem. 66 (2001) 3704;